Bridging Sunitinib Exposure to Time-to-Tumor Progression in Hepatocellular Carcinoma Patients With Mathematical Modeling of an Angiogenic Biomarker.
about
Bridging Sunitinib Exposure to Time-to-Tumor Progression in Hepatocellular Carcinoma Patients With Mathematical Modeling of an Angiogenic Biomarker.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bridging Sunitinib Exposure to ...... ng of an Angiogenic Biomarker.
@en
Bridging Sunitinib Exposure to ...... ng of an Angiogenic Biomarker.
@nl
type
label
Bridging Sunitinib Exposure to ...... ng of an Angiogenic Biomarker.
@en
Bridging Sunitinib Exposure to ...... ng of an Angiogenic Biomarker.
@nl
prefLabel
Bridging Sunitinib Exposure to ...... ng of an Angiogenic Biomarker.
@en
Bridging Sunitinib Exposure to ...... ng of an Angiogenic Biomarker.
@nl
P2093
P2860
P356
P1476
Bridging Sunitinib Exposure to ...... ng of an Angiogenic Biomarker.
@en
P2093
G Fetterly
G Tomaszewski
S Ait-Oudhia
P2860
P304
P356
10.1002/PSP4.12084
P577
2016-06-08T00:00:00Z